← Leaderboards
Carl Backes
Research Inst Nationwide Children'S Hosp
$4,408,879
Attributed
$9,706,245
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,706,245 · 6
By mechanism
UH3$3,737,522 · 2
R01$3,191,066 · 1
UG3$1,719,521 · 2
T32$1,058,136 · 1
Top collaborators
- Jonathan Lee Slaughter9 shared
- Vidu Garg3 shared
- Kevin Dennis Hill3 shared
- Anup C Katheria3 shared
Most similar at Research Inst Nationwide Children'S Hosp
Same institution · by research overlap
- Christopher Kane Breuer$17,456,519
- Vidu Garg$10,712,827
- Jonathan Lee Slaughter$5,056,850
- Mingtao Zhao$2,889,707
- Peter White$1,725,496
Others in their field
Other Emerging Leaders on “Public Health”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Mark Marino · Venturewell$51,488,542
- Susan M Landau · University Of California Berkeley$47,252,026
- Leonard Freedman · Leidos Biomedical Research, Inc.$39,554,144
Research focus
Public HealthGrowth And Development FunctionVulnerable PopulationsInfantMissionBirthOperative Surgical ProceduresUnited States National Institutes Of HealthPostnatalMortalityPregnancyFetalLeftPharmaceutical PreparationsChronic Lung DiseaseLinkPatent Ductus ArteriosusArteriesInfant HealthNeurodevelopmentBrainBrain InjuriesDuct (Organ) StructureIn Utero
Grant awards (15)
1/2 CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease$902,544
UH3 · FY2025 · HL · contact PI
1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL)$532,533
UH3 · FY2025 · HL · contact PI
Integrative Research Training Program in Pediatric Cardiopulmonary Disease$349,536
T32 · FY2025 · HL
1/2 CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease$855,663
UH3 · FY2024 · HL · contact PI
1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL)$700,785
UH3 · FY2024 · HL · contact PI
Integrative Research Training Program in Pediatric Cardiopulmonary Disease$369,366
T32 · FY2024 · HL
1/2 CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease$907,257
UG3 · FY2023 · HL · contact PI
1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL)$745,997
UH3 · FY2023 · HL · contact PI
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes$562,405
R01 · FY2023 · HL
Integrative Research Training Program in Pediatric Cardiopulmonary Disease$339,234
T32 · FY2023 · HL
1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL)$812,264
UG3 · FY2022 · HL · contact PI
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes$560,382
R01 · FY2022 · HL
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes$720,809
R01 · FY2021 · HL
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes$678,150
R01 · FY2020 · HL
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes$669,320
R01 · FY2019 · HL